[Efficacy and tolerability of linezolid therapy in the treatment of orthopedic implant infections caused by gram-positive multiresistant cocci].
Jover-Diaz
F
F
Talents
A
A
Alcalá-Santaella
R
R
Cuadrado
J M
JM
Olmedo
N
N
Gazquez
C
C
D000081:Acetamides / Q000627:therapeutic use*; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D005593:Fracture Fixation, Internal / Q000009:adverse effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D000069349:Linezolid; D008297:Male; D010019:Osteomyelitis / Q000188:drug therapy* / Q000382:microbiology*; D023303:Oxazolidinones / Q000627:therapeutic use*; D016459:Prosthesis-Related Infections / Q000188:drug therapy*; D012189:Retrospective Studies
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid